Cellectis (CLLS) Misses Q2 EPS by 29c

Cellectis (NASDAQ: CLLS) reported Q2 EPS of ($0.80), $0.29 worse than the analyst estimate of ($0.51). Revenue for the quarter came in at $14.62 million versus the consensus estimate of $23.46 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• BMO Capital Upgrades CES Energy Solutions Corp. (CEU:CN) (CESDF) to Outperform
• St. James's Place plc (STJ:LN) (STJPF) PT Raised to GBP20.50 at Deutsche Bank